Procarbazine Articles
Japan stock market week to February 28
7 March 2005
Chugai gets expanded indications for natulan
7 March 2005
Partial backing for temozolomide from US ODAC
13 January 1999
CPMP Backing For S-P's Temodal
28 October 1998
Pacific Pharmaceuticals To Enter Clinic With BOPP
1 April 1998
Sugen Moves Into Ph III With SU101
21 January 1998
Showing 1-7 of 7 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Pfizer to split-off remaining 80% interest in Zoetis
